Welcome to Medications.com

AstraZeneca warns of tough market - Financial Times

It said gains from MedImmune would be offset by lower sales in the US of Toprol-XL, a heart drug, which has lost patients to a generic alternative. ...

http://www.ft.com/cms/s/3ebd9842-... | Posted: Thu Jan 31 07:32:34 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea